Literature DB >> 1939194

Mechanism-based inactivation of alanine racemase by 3-halovinylglycines.

N A Thornberry1, H G Bull, D Taub, K E Wilson, G Giménez-Gallego, A Rosegay, D D Soderman, A A Patchett.   

Abstract

Alanine racemase, an enzyme important to bacterial cell wall synthesis, is irreversibly inactivated by 3-chloro- and 3-fluorovinylglycine. Using alanine racemase purified to homogeneity from Escherichia coli B, the efficient inactivation produced a lethal event for every 2.2 +/- 0.2 nonlethal turnovers, compared to 1 in 800 for fluoroalanine. The mechanism of inhibition involves enzyme-catalyzed halide elimination to form an allenic intermediate that partitions between reversible and irreversible covalent adducts, in the ratio 3:7. The reversible adduct (lambda max = 516 nm) decays to regenerate free enzyme with a half-life of 23 min. The lethal event involves irreversible alkylation of a tyrosine residue in the sequence -Val-Gly-Tyr-Gly-Gly-Arg. The second-order rate constant for this process with D-chlorovinylglycine (122 +/- 14 M-1 s-1), the most reactive analog examined, is faster than the equivalent rate constant for D-fluoroalanine (93 M-1 s-1). The high killing efficiency and fast turnover of these mechanism-based inhibitors suggest that their design, employing the haloethylene moiety to generate a reactive allene during catalysis, could be extended to provide useful inhibitors of a variety of enzymes that conduct carbanion chemistry.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939194

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Creation of a broad-range and highly stereoselective D-amino acid dehydrogenase for the one-step synthesis of D-amino acids.

Authors:  Kavitha Vedha-Peters; Manjula Gunawardana; J David Rozzell; Scott J Novick
Journal:  J Am Chem Soc       Date:  2006-08-23       Impact factor: 15.419

2.  Synthesis of Higher α-Chlorovinyl and α-Bromovinyl Amino Acids: The Amino Protecting Group Determines the Reaction Course.

Authors:  David B Berkowitz; Michelle L Pedersen; Wan-Jin Jahng
Journal:  Tetrahedron Lett       Date:  1996-06-17       Impact factor: 2.415

3.  Mechanism of Inactivation of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid.

Authors:  Matthew J Moschitto; Peter F Doubleday; Daniel S Catlin; Neil L Kelleher; Dali Liu; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2019-06-28       Impact factor: 15.419

4.  Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.

Authors:  Christopher D McCune; Matthew L Beio; Jill M Sturdivant; Roberto de la Salud-Bea; Brendan M Darnell; David B Berkowitz
Journal:  J Am Chem Soc       Date:  2017-09-28       Impact factor: 15.419

5.  Competing Substrates for the Bifunctional Diaminopimelic Acid Epimerase/Glutamate Racemase Modulate Peptidoglycan Synthesis in Chlamydia trachomatis.

Authors:  Raghuveer Singh; Jessica A Slade; Mary Brockett; Daniel Mendez; George W Liechti; Anthony T Maurelli
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

6.  Organization and expression of the Escherichia coli K-12 dad operon encoding the smaller subunit of D-amino acid dehydrogenase and the catabolic alanine racemase.

Authors:  M Lobocka; J Hennig; J Wild; T Kłopotowski
Journal:  J Bacteriol       Date:  1994-03       Impact factor: 3.490

7.  Use of Fluorinated Functionality in Enzyme Inhibitor Development: Mechanistic and Analytical Advantages.

Authors:  David B Berkowitz; Kannan R Karukurichi; Roberto de la Salud-Bea; David L Nelson; Christopher D McCune
Journal:  J Fluor Chem       Date:  2008-09       Impact factor: 2.050

Review 8.  Amino Acid Based Antimicrobial Agents - Synthesis and Properties.

Authors:  Michał G Nowak; Andrzej S Skwarecki; Maria J Milewska
Journal:  ChemMedChem       Date:  2021-10-01       Impact factor: 3.540

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.